Mansi R - Search Results

1

Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells.

Accardo A, Mansi R, Salzano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Ziaco B, Tesauro D, Aloj L, De Rosa G, Morelli G. Accardo A, et al. Among authors: mansi r. J Drug Target. 2013 Apr;21(3):240-249. doi: 10.3109/1061186X.2012.741138. Epub 2012 Nov 21. J Drug Target. 2013. PMID: 23167653

2

⁶¹Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.

Basaco Bernabeu T, Mansi R, Del Pozzo L, Zanger S, Gaonkar RH, McDougall L, De Rose F, Jaafar-Thiel L, Herz M, Eiber M, Ulaner GA, Weber WA, Fani M. Basaco Bernabeu T, et al. Among authors: mansi r. J Nucl Med. 2024 Sep 3;65(9):1427-1434. doi: 10.2967/jnumed.123.267126. J Nucl Med. 2024. PMID: 39025646 Free PMC article.

3

CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (^123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors.

Grand-Guillaume J, Mansi R, Gaonkar RH, Zanger S, Fani M, Eugster PJ, Beck Popovic M, Grouzmann E, Abid K. Grand-Guillaume J, et al. Among authors: mansi r. J Transl Med. 2023 Sep 7;21(1):604. doi: 10.1186/s12967-023-04466-z. J Transl Med. 2023. PMID: 37679770 Free PMC article.

4

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [¹⁷⁷Lu]Lu-PP-F11N in humans: the lumed phase 0b study.

Rottenburger C, Hentschel M, Fürstner M, McDougall L, Kottoros D, Kaul F, Mansi R, Fani M, Vija AH, Schibli R, Geistlich S, Behe M, Christ ER, Wild D. Rottenburger C, et al. Among authors: mansi r. EJNMMI Res. 2024 Apr 6;14(1):37. doi: 10.1186/s13550-024-01101-w. EJNMMI Res. 2024. PMID: 38581480 Free PMC article.

5

In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.

Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M. Aloj L, et al. Among authors: mansi r. Cancer Biother Radiopharm. 2004 Feb;19(1):93-8. doi: 10.1089/108497804773391739. Cancer Biother Radiopharm. 2004. PMID: 15068617

6

Criteria for the design and biological characterization of radiolabeled peptide-based pharmaceuticals.

Benedetti E, Morelli G, Accardo A, Mansi R, Tesauro D, Aloj L. Benedetti E, et al. Among authors: mansi r. BioDrugs. 2004;18(5):279-95. doi: 10.2165/00063030-200418050-00001. BioDrugs. 2004. PMID: 15377171 Review.

7

Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization.

Mansi R, Tesauro D, De Capua A, Fattorusso R, Caracò C, Aloj L, Benedetti E, Morelli G. Mansi R, et al. Biopolymers. 2004;76(6):527-34. doi: 10.1002/bip.20169. Biopolymers. 2004. PMID: 15526334

8

Peptide modified nanocarriers for selective targeting of bombesin receptors.

Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G. Accardo A, et al. Among authors: mansi r. Mol Biosyst. 2010 May;6(5):878-87. doi: 10.1039/b923147a. Epub 2010 Feb 9. Mol Biosyst. 2010. PMID: 20567774

9

Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.

Aloj L, Aurilio M, Rinaldi V, D'ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, de Jong M. Aloj L, et al. Among authors: mansi r. Eur J Nucl Med Mol Imaging. 2011 Aug;38(8):1417-25. doi: 10.1007/s00259-011-1816-y. Epub 2011 Apr 20. Eur J Nucl Med Mol Imaging. 2011. PMID: 21523391 Free article.

10

Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens.

Galdiero S, Vitiello M, Finamore E, Mansi R, Galdiero M, Morelli G, Tesauro D. Galdiero S, et al. Among authors: mansi r. Mol Biosyst. 2012 Oct 30;8(12):3166-77. doi: 10.1039/c2mb25064k. Mol Biosyst. 2012. PMID: 22710358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters